期刊文献+

血管紧张素Ⅱ对外周血内皮祖细胞的影响 被引量:9

Effects of angiotensinⅡ on peripheral blood endothelial progenitor cells
原文传递
导出
摘要 目的 观察血管紧张素Ⅱ (AngⅡ )对外周血内皮祖细胞 (EPCs)数量和功能的影响。方法 密度梯度离心法获取外周血单个核细胞 (MNCs) ,培养 7d后 ,收集贴壁细胞并加入不同浓度AngⅡ (10 -3 mol/L、10 -5mol/L、10 -7mol/L、10 -9mol/L)干预一定时间 (6、12、2 4h和 4 8h)。多波长激光共聚焦显微镜鉴定FITC标记荆豆凝集素Ⅰ和DiI标记的乙酰化低密度脂蛋白双染色细胞为正在分化的EPCs ,流式细胞仪检测其表面标志进一步鉴定EPCs,倒置荧光显微镜下计数。分别观察EPCs的增殖、迁移、黏附和体外血管生成能力 ,并观察缬沙坦的影响。结果 AngⅡ促进外周血EPCs扩增 ,10 3 mol/LAngⅡ作用 2 4h对EPCs数量的影响最为显著 (P <0 0 1)。AngⅡ也显著增强了外周血EPCs的黏附、迁移、增殖和体外血管生成能力。而缬沙坦可显著抑制AngⅡ的这些作用。结论 AngⅡ可通过血管紧张素 1受体介导增加EPCs数量、改善其功能 ,并呈浓度和时间依赖性。 Objective To investigate the effect of AngiotensinⅡ(AngⅡ) on the quantity proliferation, migration and adhesion of endothelial progenitor cells (EPCs).Methods Total mononuclear cells (MNCs) were isolated from peripheral blood by Ficoll density gradient centrifugation and then the cells were plated on fibronectin coated culture dishes. After 7 days of culture, several groups of attached cells were incubated with AngⅡ(to make a series of concentrations: 10 -3 mol/L,10 -5 mol/L,10 -7 mol/L,10 -9 mol/L) or vehicle control for the respective time points (6 , 12 , 24 h and 48 h). In other groups of EPCs,valsartan(1×10 -5 mol/L)and AngⅡ were added to the culture medium together.EPCs were characterized as adherent cells double positive for DiLDL uptake and lectin binding by direct fluorescent staining under a laser scanning confocal microscope. EPCs were further documented by demonstrating the expression of KDR, VEGFR 2 and AC133 with flow cytometry. EPCs proliferation, migration and in vitro vasculogenesis activity were assayed with MTT assay, modified Boyden chamber assay and in vitro vasculogenesis kit, respectively. EPCs adhesion assay was performed by replating MNCs on fibronectin coated dishes.Results Incubation of isolated human MNCs with AngⅡ increased the number of EPCs, with a maximum at 10 -3 mol/L after 24 hours ( P <0 01). In addition, AngⅡ promotes EPCs proliferative, migratory, adhesive and in vitro vasculogenetic capacity. The effect of AngⅡwas blocked by pretreatment of valsartan.Conclusions It is suggested that angiotensinⅡ may promote EPCs augmentation and enhance its functional activity through angiotensin receptor.
出处 《中华内科杂志》 CAS CSCD 北大核心 2005年第1期34-37,共4页 Chinese Journal of Internal Medicine
关键词 AngⅡ 外周血 内皮祖细胞 观察 体外 血管紧张素Ⅱ 缬沙坦 EPC 数量 影响 AngiotensinⅡ Receptor,angiotensin Endothelial growth factors
  • 相关文献

参考文献14

  • 1Otani A, Takagi H, Suzuma K, et al. Angiotensin Ⅱ potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res, 1998,82:619-628.
  • 2Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003,348:593-600.
  • 3Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation,2002 ,105:3017-30.24.
  • 4Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A, 2000 , 97:3422-3427.
  • 5Vasa M, Fiehtlseherer S, Aieher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Cite Res, 2001,89:E1-E7.
  • 6Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997,275:964-967.
  • 7Peichev M, Naiyer A J, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34( + ) cells identifies a population of functional endothelial precursors. Blood, 2000 ,95:952-958.
  • 8Murayama T, Tepper oM, Silver M, et al. Determination of bone man-ow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol,2002, 30:967-972.
  • 9Suzuki T, Nishida M, Futami S, et al. Neocndothelialization after peripheral blood stem cell transplantation in humans : a case report of a Tokaimura nuclear accident victim. Cardiovasc Rcs ,2003,58:487-492.
  • 10Sasaki K, Murohara T, Ikeda H, et al. Evidence for the importance of angiotensin Ⅱ type 1 receptor in ischemia-induced angiogenesis. J Clin Invest ,2002,109:603-611.

同被引文献98

  • 1严轶文,孙宝贵,戴秋艳.外周血单个核细胞向血管内皮祖细胞分化的体外研究[J].中国心血管病研究,2005,3(3):218-221. 被引量:5
  • 2Paczakowska E, Kucia M, Koziarska D, et al. Clinical evidence that very small embryonic-like stem cells are mobilized into peripheral blood in patients after stroke. Stroke, 2009, 40: 1237-1244.
  • 3Sutherland DR, Anderson L, Kceney M, et al. The ISHAGE guidelines for CD34^+ cell determination by flow cytometry. Intermational Society of Hematotherapy and Graft Engineering. J Hematother, 1996, 5: 213-226.
  • 4Fadini GP, Agostini C, Avogaro A. Endothelial progenitor cells in cerebrovascular disease. Sttoke, 2005, 36:1112-1113.
  • 5Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature, 2002, 416: 542-545.
  • 6Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275: 964-967.
  • 7Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000, 97: 3422-3427.
  • 8Lau KK, Chan YH, Yiu KH, et al. Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension. J Hum Hypertens, 2007, 21: 445- 451.
  • 9Taguchi A, Matsuyama T, Moriwaki H, et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation, 2004, 109: 2972-2975.
  • 10van Zonneveld AJ, Rahelink TJ. Endothelial progenitor cells: biology and therapeutic potential in hypertension. Curr Opin Nephrol Hypertens, 2006, 15: 167-172.

引证文献9

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部